• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺嘌呤核苷及冠状动脉微循环中的腺嘌呤核苷受体介导作用。

Adenosine and adenosine receptor-mediated action in coronary microcirculation.

机构信息

The International Collaborative Centre On Big Science Plan for Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria.

出版信息

Basic Res Cardiol. 2021 Mar 23;116(1):22. doi: 10.1007/s00395-021-00859-7.

DOI:10.1007/s00395-021-00859-7
PMID:33755785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987637/
Abstract

Adenosine is an ubiquitous extracellular signaling molecule and plays a fundamental role in the regulation of coronary microcirculation through activation of adenosine receptors (ARs). Adenosine is regulated by various enzymes and nucleoside transporters for its balance between intra- and extracellular compartments. Adenosine-mediated coronary microvascular tone and reactive hyperemia are through receptors mainly involving AR activation on both endothelial and smooth muscle cells, but also involving interaction among other ARs. Activation of ARs further stimulates downstream targets of HO, K, K and K channels leading to coronary vasodilation. An altered adenosine-ARs signaling in coronary microcirculation has been observed in several cardiovascular diseases including hypertension, diabetes, atherosclerosis and ischemic heart disease. Adenosine as a metabolite and its receptors have been studied for its both therapeutic and diagnostic abilities. The present review summarizes important aspects of adenosine metabolism and AR-mediated actions in the coronary microcirculation.

摘要

腺苷是一种普遍存在的细胞外信号分子,通过激活腺苷受体(AR)在调节冠状动脉微循环中起着至关重要的作用。腺苷通过各种酶和核苷转运体来调节其在细胞内外间隙的平衡。腺苷介导的冠状动脉微血管张力和反应性充血是通过受体实现的,主要涉及内皮细胞和平滑肌细胞上的 AR 激活,但也涉及其他 AR 之间的相互作用。AR 的激活进一步刺激 HO、K、K 和 K 通道的下游靶标,导致冠状动脉扩张。在包括高血压、糖尿病、动脉粥样硬化和缺血性心脏病在内的几种心血管疾病中,已经观察到冠状动脉微循环中腺苷-AR 信号的改变。作为一种代谢物,腺苷及其受体因其治疗和诊断能力而受到研究。本综述总结了腺苷代谢和 AR 介导的冠状动脉微循环作用的重要方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc4/7987637/7b57042157f2/395_2021_859_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc4/7987637/dd482171b585/395_2021_859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc4/7987637/7b57042157f2/395_2021_859_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc4/7987637/dd482171b585/395_2021_859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc4/7987637/7b57042157f2/395_2021_859_Fig2_HTML.jpg

相似文献

1
Adenosine and adenosine receptor-mediated action in coronary microcirculation.腺嘌呤核苷及冠状动脉微循环中的腺嘌呤核苷受体介导作用。
Basic Res Cardiol. 2021 Mar 23;116(1):22. doi: 10.1007/s00395-021-00859-7.
2
Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper.通过激活生理、细胞和分子机制,经常进行有氧运动对冠状动脉大、微血管的功能和结构的适应性改变:ESC 冠状动脉病理生理学和微循环工作组立场文件。
Cardiovasc Res. 2022 Jan 29;118(2):357-371. doi: 10.1093/cvr/cvab246.
3
A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts.A1 腺苷受体通过拮抗 A2A 介导的 H2O2 产生和 KATP 开放负性调节分离小鼠心脏的冠状血管反应性充血。
Am J Physiol Heart Circ Physiol. 2013 Dec 1;305(11):H1668-79. doi: 10.1152/ajpheart.00495.2013. Epub 2013 Sep 16.
4
The microcirculation: a key player in obesity-associated cardiovascular disease.微循环:肥胖相关心血管疾病的关键因素。
Cardiovasc Res. 2017 Jul 1;113(9):1035-1045. doi: 10.1093/cvr/cvx093.
5
Metabolic hyperemia requires ATP-sensitive K+ channels and H2O2 but not adenosine in isolated mouse hearts.在离体小鼠心脏中,代谢性充血需要ATP敏感性钾通道和过氧化氢,但不需要腺苷。
Am J Physiol Heart Circ Physiol. 2014 Oct 1;307(7):H1046-55. doi: 10.1152/ajpheart.00421.2014. Epub 2014 Aug 8.
6
Coronary Microvascular Dysfunction.冠状动脉微血管功能障碍。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1625-1637. doi: 10.1161/ATVBAHA.121.316025. Epub 2021 Mar 25.
7
Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.介导冠状动脉微血管对腺苷舒张反应的受体亚型的功能和分子特征
J Mol Cell Cardiol. 2001 Feb;33(2):271-82. doi: 10.1006/jmcc.2000.1298.
8
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation.电压依赖性钾通道调节犬冠状动脉循环中反应性充血的持续时间。
Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2371-81. doi: 10.1152/ajpheart.01279.2007. Epub 2008 Mar 28.
9
Important Roles of Endothelium-Dependent Hyperpolarization in Coronary Microcirculation and Cardiac Diastolic Function in Mice.内皮依赖性超极化在小鼠冠状动脉微循环和心脏舒张功能中的重要作用。
J Cardiovasc Pharmacol. 2020 Jan;75(1):31-40. doi: 10.1097/FJC.0000000000000763.
10
Activation of adenosine A but not A receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation.尿苷三磷酸诱导的猪冠状动脉平滑肌松弛与腺嘌呤 A 但非 A 受体的激活有关。
J Pharmacol Sci. 2019 Sep;141(1):64-69. doi: 10.1016/j.jphs.2019.09.006. Epub 2019 Sep 27.

引用本文的文献

1
Effects of Moso bamboo tubes on color, aroma, physicochemical properties and composition of bitter buckwheat liquor.毛竹管对苦荞酒色泽、香气、理化性质及成分的影响
Sci Rep. 2025 Aug 27;15(1):31608. doi: 10.1038/s41598-025-16966-7.
2
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?靶向腺苷受体的合成小分子配体:对缺血性心脏病有潜在作用吗?
Cells. 2025 Aug 7;14(15):1219. doi: 10.3390/cells14151219.
3
Molecular Mechanisms of Microvascular Obstruction and Dysfunction in Percutaneous Coronary Interventions: From Pathophysiology to Therapeutics-A Comprehensive Review.

本文引用的文献

1
Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction.缺血性心脏病病理生理学范式概述:从斑块激活到微血管功能障碍。
Int J Mol Sci. 2020 Oct 30;21(21):8118. doi: 10.3390/ijms21218118.
2
Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling?替格瑞洛:一种针对红细胞介导的嘌呤能信号的心脏代谢药物?
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H90-H94. doi: 10.1152/ajpheart.00570.2020. Epub 2020 Oct 23.
3
More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease.
经皮冠状动脉介入治疗中微血管阻塞与功能障碍的分子机制:从病理生理学到治疗学——全面综述
Int J Mol Sci. 2025 Jul 16;26(14):6835. doi: 10.3390/ijms26146835.
4
Inflammation mediated glycolipid dysregulation in coronary microvascular disease pathogenesis.炎症介导的糖脂代谢失调在冠状动脉微血管疾病发病机制中的作用
Sci Rep. 2025 Jul 2;15(1):22694. doi: 10.1038/s41598-025-08057-4.
5
Potassium as an electro-metabolic signal for local coronary vasodilation.钾作为局部冠状动脉血管舒张的电代谢信号。
Basic Res Cardiol. 2025 Jun 25. doi: 10.1007/s00395-025-01126-9.
6
Erythrocytes enhance oxygen-carrying capacity through self-regulation.红细胞通过自我调节增强携氧能力。
Front Physiol. 2025 May 16;16:1592176. doi: 10.3389/fphys.2025.1592176. eCollection 2025.
7
Endothelial dysfunction in chronic kidney disease: a clinical perspective.慢性肾脏病中的内皮功能障碍:临床视角
Am J Physiol Heart Circ Physiol. 2025 Jul 1;329(1):H135-H153. doi: 10.1152/ajpheart.00908.2024. Epub 2025 May 27.
8
Exploring Treatment Protocol Adherence and Variations in Paroxysmal Supraventricular Tachycardia in the Emergency Department: A Multi-Center Cohort Study.急诊科阵发性室上性心动过速治疗方案的依从性及差异探索:一项多中心队列研究
Med Sci (Basel). 2025 May 9;13(2):58. doi: 10.3390/medsci13020058.
9
Involvement of purinergic signalling in the vasomotor response to hypochlorous acid in porcine coronary artery.嘌呤能信号传导在猪冠状动脉对次氯酸的血管舒缩反应中的作用
Purinergic Signal. 2025 Apr 16. doi: 10.1007/s11302-025-10086-7.
10
Advances in the diagnosis and management of post-percutaneous coronary intervention coronary microvascular dysfunction: Insights into pathophysiology and metabolic risk interactions.经皮冠状动脉介入治疗后冠状动脉微血管功能障碍的诊断与管理进展:对病理生理学和代谢风险相互作用的见解
World J Cardiol. 2025 Feb 26;17(2):103950. doi: 10.4330/wjc.v17.i2.103950.
更多嘌呤能受体值得作为心血管疾病治疗的治疗靶点引起关注。
Am J Physiol Heart Circ Physiol. 2020 Oct 1;319(4):H723-H729. doi: 10.1152/ajpheart.00417.2020. Epub 2020 Aug 21.
4
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.心肌缺血再灌注损伤及心肌保护的展望。
Nat Rev Cardiol. 2020 Dec;17(12):773-789. doi: 10.1038/s41569-020-0403-y. Epub 2020 Jul 3.
5
Treatment of coronary microvascular dysfunction.冠状动脉微血管功能障碍的治疗。
Cardiovasc Res. 2020 Mar 1;116(4):856-870. doi: 10.1093/cvr/cvaa006.
6
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial.替格瑞洛与稳定型冠状动脉疾病患者的预处理(TAPER-S):一项随机先导临床试验。
Trials. 2020 Feb 17;21(1):192. doi: 10.1186/s13063-020-4116-7.
7
Alteration of purinergic signaling in diabetes: Focus on vascular function.糖尿病中嘌呤能信号的改变:关注血管功能。
J Mol Cell Cardiol. 2020 Mar;140:1-9. doi: 10.1016/j.yjmcc.2020.02.004. Epub 2020 Feb 11.
8
Experimental animal models of coronary microvascular dysfunction.冠状动脉微血管功能障碍的实验动物模型。
Cardiovasc Res. 2020 Mar 1;116(4):756-770. doi: 10.1093/cvr/cvaa002.
9
Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies.动脉粥样硬化与毛细血管网络:病理生理学与潜在治疗策略。
Cells. 2019 Dec 24;9(1):50. doi: 10.3390/cells9010050.
10
Activation of adenosine A but not A receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation.尿苷三磷酸诱导的猪冠状动脉平滑肌松弛与腺嘌呤 A 但非 A 受体的激活有关。
J Pharmacol Sci. 2019 Sep;141(1):64-69. doi: 10.1016/j.jphs.2019.09.006. Epub 2019 Sep 27.